Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...
GlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug conjugate (ADC), GSK’227 has gained priority medicines (PRIME) ...